MDR-TB Treatment & Prevention
Multidrug-Resistant Tuberculosis (TB) Resistant to Fluoroquinolones and Streptomycin but Susceptible to Second-Line Injection Therapy Has a Better Prognosis than Extensively Drug-Resistant TB
This new article is very interesting and fully available for free (Acrobat PDF version here attached or use this link: http://www.journals.uchicago.edu/doi/full/10.1086/597010)
The initial and long-term outcomes among a group of patients with MDR TB resistant to fluoroquinolones and streptomycin but susceptible to second-line injectables [Kanamycin, Amikacin, Capreomycin] were similar to outcomes among patients with MDR TB only [susceptible to fluoroquinolones and injectables] and significantly better than outcomes among patients with XDR TB.
Attached resource:
Replies (0)
Add reply
Recommend
0
